...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Authors' response to is angioedema a class side-effect of the angiotensin-converting enzyme inhibitors?
【24h】

Authors' response to is angioedema a class side-effect of the angiotensin-converting enzyme inhibitors?

机译:作者对血管性水肿是否是血管紧张素转化酶抑制剂的一类副作用?

获取原文
获取原文并翻译 | 示例

摘要

Drs Karagiannis, Tziomalos, and Athyros describe a patient who developed severe upper airway angioedema that necessitated an emergency tracheostomy.1-2 The patient had been treated with ramipril for the previous 3 years. After recovery, another physician administered trandolapril, and within 2 days, angioedema recurred. In our article,3 as noted in Table 1, 4 patients had experienced episodes of angiotensin-converting enzyme inhibitor (ACEI)-associated angioedema before presentation to the hospital, In fact, 2 patients had reported 2 prior episodes of angioedema, and 2 patients had experienced a single episode before presentation.
机译:Karagiannis,Tziomalos和Athyros博士描述了一名患者,该患者发生严重的上呼吸道血管性水肿,需要紧急气管切开术。1-2该患者在过去3年中接受过雷米普利治疗。康复后,另一位医生使用了trandolapril,并在2天内复发了血管性水肿。如表1所述,在我们的文章3中,有4位患者在就诊之前经历了与血管紧张素转换酶抑制剂(ACEI)相关的血管性水肿发作,实际上,有2例患者报告了2例先前的血管性水肿发作,还有2例患者在演示之前经历过一个情节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号